QC
TXG icon

Quadrature Capital’s 10x Genomics TXG Stock Holding History

Quadrature Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,932
Closed -$122K – 1515
2025
Q1 		$122K Buy
+13,932
New +$176K ﹤0.01% 917
2024
Q3 		– Sell
-42,755
Closed -$830K – 1399
2024
Q2 		$830K Buy
+42,755
New +$1.12M 0.01% 507

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quadrature Capital's TXG Position: Q2 2025 in Review

Quadrature Capital sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 13,932 shares — an estimated $122K sold.

Quadrature Capital first reported a position in TXG in Q2 2024 and held it in 2 quarters. The position peaked at $830K in Q2 2024. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Quadrature Capital reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Quadrature Capital sold 13,932 10x Genomics shares in Q2 2025, an estimated $122K.
  • Quadrature Capital first reported a position in 10x Genomics in Q2 2024 and held it in 2 quarters.
  • Quadrature Capital's 10x Genomics position peaked at $830K in Q2 2024.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.